Lantheus Holdings, Inc.
corporate_fare Company Profile
Lantheus Holdings, Inc. (NASDAQ:LNTH) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 37 items for LNTH at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-12, rated 7/10. Across its 20 most recent items scored 7 or higher, the top rating is 10/10, with 7 rated 8 or above. Recent SEC coverage for LNTH spans SCHEDULE 13D/A, 10-Q, 8-K, DEFM14A.
Recent high-impact activity:
- Lantheus Exits Perspective Therapeutics Stake, Selling 4M Shares
- Lantheus to Divest CDMO Business and New Jersey Plant to PharmaLogic
- Lantheus Beats Q3 Estimates With $1.68 Adjusted EPS, Revenue Up 1.5%
- Lantheus Q3: Revenue $389.9M, $31M IPR&D Impairment, Cash Builds to $683.6M
- Lantheus Posts $389.9M in Q3 Revenue, Edging Past Q2's $388.2M
Financial Snapshot
Short Interest & Short Volume
3.23 days to coverFINRA reported short interest of 3,640,835 shares in LNTH as of the October 30, 2026 settlement, a 0.2% increase from the prior period — about 3.2 days to cover at its recent average daily volume. On November 20, 2026, 40.7% of LNTH volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.